The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bearden, C. E.
* Articles by Simon, T. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bearden, C. E.
* Articles by Simon, T. J.
Related Collections
* Genetics
* Cognition
Am J Psychiatry 161:1700-1702, September 2004
© 2004 American Psychiatric Association


Brief Report

Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion Syndrome

Carrie E. Bearden, Ph.D., Abbas F. Jawad, Ph.D., David R. Lynch, M.D., Ph.D., Set Sokol, B.A., Steven J. Kanes, M.D., Ph.D., Donna M. McDonald-McGinn, M.S., Sulagna C. Saitta, M.D., Ph.D., Stacy E. Harris, B.S., Edward Moss, Ph.D., Paul P. Wang, M.D., Elaine Zackai, M.D., Beverly S. Emanuel, Ph.D., and Tony J. Simon, Ph.D.

OBJECTIVE: The 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome) is associated with attentional problems and executive dysfunction, and is one of the highest known risk factors for schizophrenia. These behavioral manifestations of 22q11.2 deletion syndrome could result from haploinsufficiency of the catechol O-methyltransferase (COMT) gene, located within the 22q11 region. The goal of the present study was to examine COMT genotype as a predictor of prefrontal cognitive function in patients with 22q11.2 deletion syndrome. METHOD: Patients with confirmed 22q11.2 deletions (N=44) underwent neurocognitive testing following Val158Met genotyping (Met hemizygous: N=16; Val hemizygous: N=28). RESULTS: Analyses of covariance revealed that Met-hemizygous patients performed significantly better on a composite measure of executive function (comprising set-shifting, verbal fluency, attention, and working memory) than did Val-hemizygous patients. CONCLUSIONS: These data are consistent with those of previous studies in normal individuals, suggesting that a functional genetic polymorphism in the 22q11 region may influence prefrontal cognition in individuals with COMT haploinsufficiency.




This article has been cited by other articles:


Home page
Cogn Affect Behav NeurosciHome page
Y. Takarae, L. Schmidt, F. Tassone, and T. J. Simon
Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome
Cogn Affect Behav Neurosci, March 1, 2009; 9(1): 83 - 90.
[Abstract] [PDF]


Home page
Cereb CortexHome page
C. E. Bearden, T. G.M. van Erp, R. A. Dutton, A. D. Lee, T. J. Simon, T. D. Cannon, B. S. Emanuel, D. McDonald-McGinn, E. H. Zackai, and P. M. Thompson
Alterations in Midline Cortical Thickness and Gyrification Patterns Mapped in Children with 22q11.2 Deletions
Cereb Cortex, January 1, 2009; 19(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. C. Mefford, A. J. Sharp, C. Baker, A. Itsara, Z. Jiang, K. Buysse, S. Huang, V. K. Maloney, J. A. Crolla, D. Baralle, et al.
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
N. Engl. J. Med., October 16, 2008; 359(16): 1685 - 1699.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
E. Tunbridge, C. Weickert, J. Kleinman, M. Herman, J Chen, B. Kolachana, P. Harrison, and D. Weinberger
Catechol-o-Methyltransferase Enzyme Activity and Protein Expression in Human Prefrontal Cortex across the Postnatal Lifespan
Cereb Cortex, May 1, 2007; 17(5): 1206 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Raux, E. Bumsel, B. Hecketsweiler, T. van Amelsvoort, J. Zinkstok, S. Manouvrier-Hanu, C. Fantini, G.-M. M. Breviere, G. Di Rosa, G. Pustorino, et al.
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Hum. Mol. Genet., January 1, 2007; 16(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. M. Drabant, A. R. Hariri, A. Meyer-Lindenberg, K. E. Munoz, V. S. Mattay, B. S. Kolachana, M. F. Egan, and D. R. Weinberger
Catechol O-methyltransferase Val158Met Genotype and Neural Mechanisms Related to Affective Arousal and Regulation
Arch Gen Psychiatry, December 1, 2006; 63(12): 1396 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
B. Glaser, M. Debbane, C. Hinard, M. A. Morris, S. P. Dahoun, S. E. Antonarakis, and S. Eliez
No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome
Am J Psychiatry, March 1, 2006; 163(3): 537 - 539.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org